Citi Maintains a 'Hold' on Pfizer (PFE); Prefers Merck (MRK)
Tweet Send to a Friend
Citi maintains a 'Hold' on Pfizer (PFE), price target $18.
Citi analyst says, "Pipeline Setbacks Continue: The HCC failure joins ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst says, "Pipeline Setbacks Continue: The HCC failure joins ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


